Pricing Log in Create free account

Rapport Therapeutics, Inc. (RAPP) vs SpyGlass Pharma, Inc. (SGP)

Rapport Therapeutics, Inc. and SpyGlass Pharma, Inc. are both Biotechnology companies. Rapport Therapeutics, Inc. and SpyGlass Pharma, Inc. are of similar size ($1.1B and $1.1B). Across the 8 metrics below, Rapport Therapeutics, Inc. leads on 5 and SpyGlass Pharma, Inc. on 3.

Valuation

Metric RAPP SGP Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.99 5.24 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (12.96%) (24.85%) (32.88%)
Free cash flow yield (10.33%) (3.81%) (23.13%)

Profitability

Metric RAPP SGP Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (33.33%) (51.34%) (51.96%)
Return on assets (31.55%) (35.97%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RAPP SGP Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 24.34% (10.25%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric RAPP SGP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 20.07 25.06 4.97
Net debt to EBITDA 3.91 2.63 1.01

Dividend

Metric RAPP SGP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric RAPP SGP Biotechnology median
Market cap 1.14b 1.14b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack